Serum MRP8/14 was higher in patients with CAD, compared with the non‐CAD group (9.7 ± 3.6 vs. 8.2 ± 3.0 ug/mL, p < 0.001). Also, its levels were associated with the severity of CAD. This evidence concerns the gene S100A8 and coronary artery disorder.